Salah‐Eddin Al‐Batran

机构：Institute of Clinical Cancer Research, Frankfurt Cancer Institute · ORCID：0000-0002-0279-8509

发表论文 371 篇 · 总被引 18298 次 · h-index 54

代表论文

Inflammatory Stress Determines the Need for Chemotherapy in Patients with HER2-Positive Esophagogastric Adenocarcinoma Receiving Targeted Therapy and Immunotherapy (2024 · Cancer Immunology Research · 被引 7)
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wildtype metastatic colorectal cancer – A subgroup analysis of the FIRE-3 (AIO KRK-0306) trial (2025 · European Journal of Cancer · 被引 5)
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors–A randomized clinical trial (IKF-010) (2025 · Clinical Nutrition ESPEN · 被引 3)
ADJUBIL: A phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in adjuvant situation for biliary tract cancer—The IKF/AIO-ADJUBIL trial. (2025 · Journal of Clinical Oncology · 被引 2)
Guidelines of Onkopedia: What Is New? (2025 · Oncology Research and Treatment · 被引 1)
IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early stage hepatocellular carcinoma (HCC)—The IKF-IMMULAB trial. (2025 · Journal of Clinical Oncology · 被引 1)